MontgomeryAB, StagerMA, CarricoCJ, HudsonLD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis, 1985; 132(3):485–489.
2.
StapletonRD, WangBM, HudsonLD, RubenfeldGD, CaldwellES, SteinbergKP. Causes and timing of death in patients with ARDS. Chest, 2005; 128(2):525–532.
3.
HanS, MallampalliRK. The acute respiratory distress syndrome: from mechanism to translation. J Immunol, 2015; 194(3):855–860.
4.
SlutskyAS, TremblayLN. Multiple system organ failure. Is mechanical ventilation a contributing factor?. Am J Respir Crit Care Med, 1998; 157(6 Pt 1):1721–1725.
5.
TremblayLN, SlutskyAS. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians, 1998; 110(6):482–488.
6.
ARDS Definition Task Force; RanieriVM, RubenfeldGD, ThompsonBT, FergusonND, CaldwellE, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA, 2012; 307(23):2526–2533.
7.
KalletR, LipnickM, ZhuoH, PangilinanL, GomezA. Characteristics of non-pulmonary organ dysfunction at the onset of ARDS based on the Berlin definition. Respir Care, 2019; 64(5):493–501.
8.
BellaniG, LaffeyJG, PhamT, FanE, BrochardL, EstebanA, et al. LUNG SAFE Investigators; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA, 2016; 315(8):788–800.
9.
VincentJL, MorenoR, TakalaJ, WillattsS, De MendoçaA, BruiningH, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med, 1996; 22(7):707–710.
10.
VillarJ, BlancoJ, del CampoR, Andaluz-OjedaD, Diaz-DominiquezFJ, MurielA, et al. Spanish Initiative for Epidemiology, Stratification & Therapies for ARDS (SIESTA) Network. Assessment of PaO2/FiO2 for stratification of patients with moderate and severe acute respiratory distress syndrome. BMJ Open, 2015; 5(3):e006812.
11.
LaffeyJG, BellaniG, PhamT, FanE, MadottoF, BajwaEK, et al. LUNG SAFE Investigators and the ESICM Trials Group. Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med, 2016; 42(12):1865–1876.
12.
Acute Respiratory Distress Syndrome Network, BrowerRG, MatthayMA, MorrisA, SchoenfeldD, ThompsonBT, WheelerA. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med, 2000; 342(18):1301–1308.
13.
PapazianL, ForelJM, GacouinA, Penot-RagonC, PerrinG, LoundouA, et al. ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med, 2010; 363(12):1107–1116.
14.
MadottoF, PhamT, BellaniG, BosLD, SimonisFD, FanE, et al. LUNG SAFE Investigators and the ESICM Trials Group. Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study. Intensive Care Med, 2018; 44(5):564–577.
15.
CalfeeCS, DelucchiK, ParsonsPE, ThompsonBT, WareLB, MatthayMA. NHLBI ARDS Network. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med, 2014; 2(8):611–620.
